Protein kinase C isozymes in hypertension and hypertrophy: Insight from SHHF rat hearts

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-005-3781-xPMID 15792354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in protein kinase C isoenzyme expression and autophosphorylation during the progression of pressure overload-induced left ventricular hypertrophy

  2004cited by this paper
• PKC-α regulates cardiac contractility and propensity toward heart failure

  2004cited by this paper
• PKC-alpha regulates cardiac contractility and propensity toward heart failure.

  2004cited by this paper
• A new chapter in cardiac PKC signaling studies: searching for isoform-specific molecular targets. Focus on: "isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes".

  2003cited by this paper
• Alterations in G Protein and MAP Kinase Signaling Pathways During Cardiac Remodeling in Hypertension and Heart Failure

  2003cited by this paper
• Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction.

  2003cited by this paper
• Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure

  2003cited by this paper
• Protein kinase C-epsilon (PKC-epsilon): its unique structure and function.

  2002cited by this paper
• Ischemic Protection and Myofibrillar Cardiomyopathy: Dose-Dependent Effects of In Vivo &dgr;PKC Inhibition

  2002cited by this paper
• Protein Kinase C-ε (PKC-ε): Its Unique Structure and Function

  2002cited by this paper
• Structural, functional, and molecular characterization of the SHHF model of heart failure.

  2002cited by this paper
• Regulation of the isozymes of protein kinase C in the surviving rat myocardium after myocardial infarction: distinct modulation for PKC-alpha and for PKC-delta.

  2002cited by this paper
• Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta.

  2002cited by this paper
• Temporal regression of myocyte hypertrophy in hypertensive, heart failure-prone rats treated with an AT1-receptor antagonist.

  2002cited by this paper
• Identification of PKCalpha isoform-specific effects in cardiac myocytes using antisense phosphorothioate oligonucleotides.

  2002cited by this paper
• Tissue Angiotensin II During Progression or Ventricular Hypertrophy to Heart Failure in Hypertensive Rats; Differential Effects on PKCε and PKCβ

  2002cited by this paper
• Regulation of the isozymes of protein kinase C in the surviving rat myocardium after myocardial infarction: distinct modulation for PKC-α and for PKC-δ

  2002cited by this paper
• Untangling the Web: specific signaling from PKC isoforms to MAPK cascades.

  2001cited by this paper
• Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation.

  2000cited by this paper
• Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.

  2000cited by this paper
• Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy.

  2000cited by this paper
• Protein kinase C and myocardial biology and function.

  2000cited by this paper
• Multiple pathways control protein kinase C phosphorylation

  2000cited by this paper
• Protein kinase C isozymes and the regulation of diverse cell responses.

  2000cited by this paper
• Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Galphaq.

  2000cited by this paper
• ε Protein Kinase C in Pathological Myocardial Hypertrophy

  2000cited by this paper
• Cardiotrophic Effects of Protein Kinase C ε Analysis by In Vivo Modulation of PKCε Translocation

  2000cited by this paper
• Transgenic Overexpression of Constitutively Active Protein Kinase C ε Causes Concentric Cardiac Hypertrophy

  2000cited by this paper
• Signal transduction during cardiac hypertrophy: the role of G alpha q, PLC beta I, and PKC.

  1999cited by this paper
• The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.

  1999cited by this paper
• Signal transduction during cardiac hypertrophy: the role of Gαq, PLC βI, and PKC

  1999cited by this paper
• Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart.

  1999cited by this paper
• Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated.

  1999cited by this paper
• New insights into the regulation of protein kinase C and novel phorbol ester receptors

  1999cited by this paper
• Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice

  1998cited by this paper
• Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.

  1998cited by this paper
• Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice.

  1998cited by this paper
• Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension.

  1998cited by this paper
• Left ventricular stretch stimulates angiotensin II--mediated phosphatidylinositol hydrolysis and protein kinase C epsilon isoform translocation in adult guinea pig hearts.

  1997cited by this paper
• Myocyte remodeling during the progression to failure in rats with hypertension.

  1996cited by this paper
• Protein kinase C isoform expression and regulation in the developing rat heart.

  1994cited by this paper
• Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes.

  1994cited by this paper
• Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.

  1993cited by this paper
• Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

  1993cited by this paper
• In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.

  1992cited by this paper
• In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.

  1992cited by this paper

• Alpha 1-antitrypsin mitigates salt-sensitive hypertension in juvenile mice by reducing diacylglycerol concentrations and protein kinase C activity in kidney membranes

  2025cites this paper
• Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review

  2019cites this paper
• Targeting protein kinase C: A novel paradigm for heart failure therapy

  2018cites this paper
• Cyclosporine-A mimicked the ischemic pre- and postconditioning-mediated cardioprotection in hypertensive rats: Role of PKCε.

  2016cites this paper
• Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

  2015cites this paper
• Assessment of the early stage of cardiac remodeling of spontaneously hypertensive heart failure rats using the quantitative 3-dimensional analysis provided by acipimox-enhanced FDG-PET

  2014cites this paper
• Expression and distribution of Src in the nucleus of myocytes in cardiac hypertrophy.

  2013cites this paper
• MITOCHONDRIAL OXIDATIVE STRESS AND PROTEIN KINASE C ARE NOT THE REGULATORS OF CARDIAC HYPERTROPHY IN MICE WITH CARDIAC SPECIFIC GLUCOSE TRANSPORTER 4 DELETION by

  2012cites this paper
• Mechanisms underlying the endothelium-dependent modulation of vascular tone

  2011cites this paper
• Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat.

  2010cites this paper
• PEPTIDERGIC REGULATION OF CARDIAC CONTRACTILITY : ROLE OF PROLACTIN-RELEASING PEPTIDE AND ENDOTHELIN-1 Ph

  2010cites this paper
• Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca2+-cycling proteins in streptozotocin-induced diabetic rats

  2010cites this paper
• Exercise preconditioning initiates late cardioprotection against isoproterenol-induced myocardial injury in rats independent of protein kinase C

  2010cites this paper
• Protein kinase C α and ε phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardium

  2009cites this paper
• PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.

  2009cites this paper
• Pharmacologic- and gene therapeutic-based inhibition of PKC α / β enhances cardiac contractility and attenuates heart failure

  2009cites this paper
• Mammalian Target of Rapamycin Is a Critical Regulator of Cardiac Hypertrophy in Spontaneously Hypertensive Rats

  2009cites this paper
• [The effect of chelerythrine on the hypertrophy of cardiac myocytes of neonatal rats induced by different glucose levels and its mechanism].

  2009influential citation
• 1,25-Dihydroxyvitamin-D3 Treatment Reduces Cardiac Hypertrophy and Left Ventricular Diameter in Spontaneously Hypertensive Heart Failure-prone (cp/+) Rats Independent of Changes in Serum Leptin

  2008cites this paper
• Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks.

  2008cites this paper
• Cardiac Hypertrophy: Mechanisms and Therapeutic Opportunities

  2007cites this paper
• PKCepsilon increases phosphorylation of the cardiac myosin binding protein C at serine 302 both in vitro and in vivo.

  2007cites this paper
• PKCε Increases Phosphorylation of the Cardiac Myosin Binding Protein C at Serine 302 both in Vitro and in Vivo

  2007cites this paper
• Augmented Protein Kinase C-α–Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure

  2007cites this paper
• Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure.

  2006cites this paper
• Nuclear compartmentalization of FAK and FRNK in cardiac myocytes.

  2006cites this paper
• Pharmacological- and Gene Therapy–Based Inhibition of Protein Kinase Cα/β Enhances Cardiac Contractility and Attenuates Heart Failure

  2006cites this paper
• Basic Science and Experimental Studies P38 MAP Kinase Activity Is Correlated With Angiotensin II Type 1 Receptor BlockereInduced Left Ventricular Reverse Remodeling in Spontaneously Hypertensive Heart Failure Rats

  2006cites this paper
• p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.

  2006cites this paper